GLI1 and acute myeloid leukemia: For instance, GLI1 protein levels were highly elevated in AML relapse patients after ribavirin monotherapy or ribavirin and low-dose cytarabine (Ara-C) combination treatment, suggesting elevated GLI1 was associated with acquired resistance [114].